This site uses cookies. To learn more, please visit our Privacy Policy. By continuing to surf on our website, you consent to our use of cookies Close [X]
Sarcopenia Treatment Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Treatment Type (Protein Supplement, Vitamin B12 Supplement, Vitamin D and Calcium Supplement); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies Hypermarket and Supermarket)
Sarcopenia is a situation characterized by a loss of skeletal muscle mass and function. Sarcopenia is a syndrome characterized by progressive and generalized loss of skeletal muscle mass and strength, and it is strictly correlated with a physical disability, poor quality of life, and death.
MARKET DYNAMICS
The sarcopenia treatment market is anticipated to grow due to increased aging and obesity. Furthermore, lack of a permanent cure for the treatment of sarcopenia increased R & D development through government policies, changes in disease management, etc. are factors driving the growth of the sarcopenia treatment market.
MARKET SCOPE
The "Sarcopenia Treatment Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of sarcopenia treatment market with detailed market segmentation by treatment type, and distribution channel. The sarcopenia treatment market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in sarcopenia treatment market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The sarcopenia treatment market is segmented on the basis of treatment type, and distribution channel. Based on treatment type the market is segmented as protein supplement, vitamin b12 supplement and vitamin d & calcium supplement. On the basis of distribution channel, the market is categorized as hospital pharmacies, retail pharmacies, online pharmacies and hypermarket & supermarket.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the sarcopenia treatment market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The sarcopenia treatment market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting sarcopenia treatment market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the sarcopenia treatment market in these regions.
Get more information on this report :
MARKET PLAYERS
The report covers key developments in the sarcopenia treatment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from sarcopenia treatment market are anticipated to have lucrative growth opportunities in the future with the rising demand for sarcopenia treatment in the global market. Below mentioned is the list of few companies engaged in the sarcopenia treatment market.
The report also includes the profiles of key players in sarcopenia treatment market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
Abbott Laboratories
Bayer AG
Cadila Healthcare Ltd.
Eli Lilly and Company
GlaxoSmithKline Plc.,
Nestlé S.A.,
Novartis AG
Pfizer Inc.,
Radius Health, Inc.
Sanofi S.A.,
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
Get more information on this report :
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Sarcopenia Treatment Market - By Treatment Type
1.3.2 Sarcopenia Treatment Market - By Distribution Channel
1.3.3 Sarcopenia Treatment Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. SARCOPENIA TREATMENT MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. SARCOPENIA TREATMENT MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. SARCOPENIA TREATMENT MARKET - GLOBAL MARKET ANALYSIS
6.1. SARCOPENIA TREATMENT - GLOBAL MARKET OVERVIEW
6.2. SARCOPENIA TREATMENT - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. SARCOPENIA TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 - TREATMENT TYPE
7.1. OVERVIEW
7.2. TREATMENT TYPE MARKET FORECASTS AND ANALYSIS
7.3. PROTEIN SUPPLEMENT
7.3.1. Overview
7.3.2. Protein Supplement Market Forecast and Analysis
7.4. VITAMIN B12 SUPPLEMENT
7.4.1. Overview
7.4.2. Vitamin B12 Supplement Market Forecast and Analysis
7.5. VITAMIN D AND CALCIUM SUPPLEMENT
7.5.1. Overview
7.5.2. Vitamin D and Calcium Supplement Market Forecast and Analysis
8. SARCOPENIA TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
8.1. OVERVIEW
8.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL PHARMACIES
8.3.1. Overview
8.3.2. Hospital Pharmacies Market Forecast and Analysis
8.4. RETAIL PHARMACIES
8.4.1. Overview
8.4.2. Retail Pharmacies Market Forecast and Analysis
8.5. ONLINE PHARMACIES HYPERMARKET AND SUPERMARKET
8.5.1. Overview
8.5.2. Online Pharmacies Hypermarket and Supermarket Market Forecast and Analysis
9. SARCOPENIA TREATMENT MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Sarcopenia Treatment Market Overview
9.1.2 North America Sarcopenia Treatment Market Forecasts and Analysis
9.1.3 North America Sarcopenia Treatment Market Forecasts and Analysis - By Treatment Type
9.1.4 North America Sarcopenia Treatment Market Forecasts and Analysis - By Distribution Channel
9.1.5 North America Sarcopenia Treatment Market Forecasts and Analysis - By Countries
9.1.5.1 United States Sarcopenia Treatment Market
9.1.5.1.1 United States Sarcopenia Treatment Market by Treatment Type
9.1.5.1.2 United States Sarcopenia Treatment Market by Distribution Channel
9.1.5.2 Canada Sarcopenia Treatment Market
9.1.5.2.1 Canada Sarcopenia Treatment Market by Treatment Type
9.1.5.2.2 Canada Sarcopenia Treatment Market by Distribution Channel
9.1.5.3 Mexico Sarcopenia Treatment Market
9.1.5.3.1 Mexico Sarcopenia Treatment Market by Treatment Type
9.1.5.3.2 Mexico Sarcopenia Treatment Market by Distribution Channel
9.2. EUROPE
9.2.1 Europe Sarcopenia Treatment Market Overview
9.2.2 Europe Sarcopenia Treatment Market Forecasts and Analysis
9.2.3 Europe Sarcopenia Treatment Market Forecasts and Analysis - By Treatment Type
9.2.4 Europe Sarcopenia Treatment Market Forecasts and Analysis - By Distribution Channel
9.2.5 Europe Sarcopenia Treatment Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Sarcopenia Treatment Market
9.2.5.1.1 Germany Sarcopenia Treatment Market by Treatment Type
9.2.5.1.2 Germany Sarcopenia Treatment Market by Distribution Channel
9.2.5.2 France Sarcopenia Treatment Market
9.2.5.2.1 France Sarcopenia Treatment Market by Treatment Type
9.2.5.2.2 France Sarcopenia Treatment Market by Distribution Channel
9.2.5.3 Italy Sarcopenia Treatment Market
9.2.5.3.1 Italy Sarcopenia Treatment Market by Treatment Type
9.2.5.3.2 Italy Sarcopenia Treatment Market by Distribution Channel
9.2.5.4 Spain Sarcopenia Treatment Market
9.2.5.4.1 Spain Sarcopenia Treatment Market by Treatment Type
9.2.5.4.2 Spain Sarcopenia Treatment Market by Distribution Channel
9.2.5.5 United Kingdom Sarcopenia Treatment Market
9.2.5.5.1 United Kingdom Sarcopenia Treatment Market by Treatment Type
9.2.5.5.2 United Kingdom Sarcopenia Treatment Market by Distribution Channel
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Sarcopenia Treatment Market Overview
9.3.2 Asia-Pacific Sarcopenia Treatment Market Forecasts and Analysis
9.3.3 Asia-Pacific Sarcopenia Treatment Market Forecasts and Analysis - By Treatment Type
9.3.4 Asia-Pacific Sarcopenia Treatment Market Forecasts and Analysis - By Distribution Channel
9.3.5 Asia-Pacific Sarcopenia Treatment Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Sarcopenia Treatment Market
9.3.5.1.1 Australia Sarcopenia Treatment Market by Treatment Type
9.3.5.1.2 Australia Sarcopenia Treatment Market by Distribution Channel
9.3.5.2 China Sarcopenia Treatment Market
9.3.5.2.1 China Sarcopenia Treatment Market by Treatment Type
9.3.5.2.2 China Sarcopenia Treatment Market by Distribution Channel
9.3.5.3 India Sarcopenia Treatment Market
9.3.5.3.1 India Sarcopenia Treatment Market by Treatment Type
9.3.5.3.2 India Sarcopenia Treatment Market by Distribution Channel
9.3.5.4 Japan Sarcopenia Treatment Market
9.3.5.4.1 Japan Sarcopenia Treatment Market by Treatment Type
9.3.5.4.2 Japan Sarcopenia Treatment Market by Distribution Channel
9.3.5.5 South Korea Sarcopenia Treatment Market
9.3.5.5.1 South Korea Sarcopenia Treatment Market by Treatment Type
9.3.5.5.2 South Korea Sarcopenia Treatment Market by Distribution Channel
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Sarcopenia Treatment Market Overview
9.4.2 Middle East and Africa Sarcopenia Treatment Market Forecasts and Analysis
9.4.3 Middle East and Africa Sarcopenia Treatment Market Forecasts and Analysis - By Treatment Type
9.4.4 Middle East and Africa Sarcopenia Treatment Market Forecasts and Analysis - By Distribution Channel
9.4.5 Middle East and Africa Sarcopenia Treatment Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Sarcopenia Treatment Market
9.4.5.1.1 South Africa Sarcopenia Treatment Market by Treatment Type
9.4.5.1.2 South Africa Sarcopenia Treatment Market by Distribution Channel
9.4.5.2 Saudi Arabia Sarcopenia Treatment Market
9.4.5.2.1 Saudi Arabia Sarcopenia Treatment Market by Treatment Type
9.4.5.2.2 Saudi Arabia Sarcopenia Treatment Market by Distribution Channel
9.4.5.3 U.A.E Sarcopenia Treatment Market
9.4.5.3.1 U.A.E Sarcopenia Treatment Market by Treatment Type
9.4.5.3.2 U.A.E Sarcopenia Treatment Market by Distribution Channel
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Sarcopenia Treatment Market Overview
9.5.2 South and Central America Sarcopenia Treatment Market Forecasts and Analysis
9.5.3 South and Central America Sarcopenia Treatment Market Forecasts and Analysis - By Treatment Type
9.5.4 South and Central America Sarcopenia Treatment Market Forecasts and Analysis - By Distribution Channel
9.5.5 South and Central America Sarcopenia Treatment Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Sarcopenia Treatment Market
9.5.5.1.1 Brazil Sarcopenia Treatment Market by Treatment Type
9.5.5.1.2 Brazil Sarcopenia Treatment Market by Distribution Channel
9.5.5.2 Argentina Sarcopenia Treatment Market
9.5.5.2.1 Argentina Sarcopenia Treatment Market by Treatment Type
9.5.5.2.2 Argentina Sarcopenia Treatment Market by Distribution Channel
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. SARCOPENIA TREATMENT MARKET, KEY COMPANY PROFILES
11.1. ABBOTT LABORATORIES
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. BAYER AG
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. CADILA HEALTHCARE LTD.
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. ELI LILLY AND COMPANY
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. GLAXOSMITHKLINE PLC.,
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. NESTLé S.A.,
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. NOVARTIS AG
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. PFIZER INC.,
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. RADIUS HEALTH, INC.
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. SANOFI S.A.,
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies
1. Abbott Laboratories
2. Bayer AG
3. Cadila Healthcare Ltd.
4. Eli Lilly and Company
5. GlaxoSmithKline Plc.,
6. Nestlé S.A.,
7. Novartis AG
8. Pfizer Inc.,
9. Radius Health, Inc.
10. Sanofi S.A.,
